Baker Tilly to be sponsor of KEIRETSU FORUM MID-ATLANTIC

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Baker Tilly to be sponsor of KEIRETSU FORUM MID-ATLANTIC 4th ANGEL CAPITAL EXPO

Philadelphia, PA, Sept. 28, 2016 (GLOBE NEWSWIRE) -- Baker Tilly, a full-service accounting and advisory firm with specialized professionals who connect with you and your business through refreshing candor and clear industry insight, has agreed to be a sponsor of Keiretsu Forum’s 4th Angel Capital Expo.  Baker Tilly has been a supporter of Keiretsu Forum mid-Atlantic since 2013 and, accordingly, a longtime supporter of the entrepreneurial community and the Angel investing community.

“Baker Tilly is an active supporter of the entrepreneurial and angel investing community,” stated James Lawson, partner with the Pittsburgh office,”and there is no better way to demonstrate this than to support the community of entrepreneurs and angel investors by partnering with Keiretsu Forum’s Pittsburgh chapter.”

The Keiretsu Forum Mid-Atlantic Region (K4-MA) – with chapters in Philadelphia, Washington, DC, Pittsburgh, and New York, a part of the global Keiretsu Forum angel network strives to foster collaboration among early stage companies, angel groups and the larger investment community.

The Angel Capital Expo will take place on Wednesday, October 26, 2016, from 7:30am – 6:30pm at Drexel University in Philadelphia, PA.  The Angel Capital Expo (ACE) was initiated in San Francisco as the signature event of Keiretsu Forum, (K4).  

Keiretsu Forum will guarantee that the regular forum entry that obtains the highest level of votes (as the favorite presentation) from attendees will receive a investments from K4 stakeholders of $200,000.

The top early stage company will receive $25,000 in services in kind from our sponsors.

Attendees of the Angel Capital Expo will include approximately 150 accredited angel investors from the Mid-Atlantic Region and elsewhere in K4’s global network of 1500+ investors, accredited investors from other area angel groups, independent angel investors, VCs, and family wealth management professionals.

The featured presenters at the Angel Capital Expo will include 12 early stage companies in Internet-SaaS-cloud technology, healthcare-life sciences-medical devices, consumer products, cleantech/energy solutions, software-security-telecommunications technologies, and real estate.  

There will also be six early - stage “Fast Pitch” presenters from various K4-MA partner technology transfer offices, college and university business plan/idea competitions, and local seed-stage programs.

“Keiretsu Forum investors have regular access to a number of quality investment opportunities” stated Howard Lubert, the founder of K4 MA. “The Angel Capital Expo will provide access to a dozen investment opportunities that have been vetted by a trusted source, opportunities to invest across diverse sectors, and entrée to other investors with comparable interests.”

Those who are interested in registering should click here  .  Details on the Expo can also be found on the K4-MA website at www.KeiretsuForum-MidAtlantic.com/Angel-Capital-Expo or you can email Info@KeiretsuForum .net or call +1 (610) 971-4067.

About Baker Tilly

Our focus on industry and service specialization means you can expect to work with business advisors who understand your competitive environment and the issues that you face.

Exceptional client service is what separates Baker Tilly from the rest. We ask. We listen. We hear you loud and clear. Learning about you, your organization, and your expectations is critical to our relationship because your definition of satisfaction is the only definition that matters. And when it comes to achieving results, our client-centric technical and industry specialists work with you and each other to deliver solutions that address your needs.

Founded in 1931, we are now one of the top 12 largest accounting and advisory firms in the US.  Baker Tilly has achieved dynamic growth while maintaining a commitment to our core values.

About Keiretsu Forum Keiretsu Forum is a global angel investor network with more than 1500 accredited investor members throughout 46 chapters on four continents.  Keiretsu Forum Mid-Atlantic ( http://www.KeiretsuForum-MidAtlantic.com ) consists of four chapters that function as a single entity – Philadelphia, Washington, DC, Pittsburgh and New York.  Keiretsu is a Japanese term for a group of organizations with interlocking business relationships, and Keiretsu Forum is a group of accredited investors with interlocking investment interests.  Each chapter or region meets monthly to present rigorously screened candidates for investments. Keiretsu Forum’s mission is “Great Association with Quality Deal Flow.”

The Mid-Atlantic Region presents approximately five deals a month, 60 a year, to its members and accredited investor guests. In 2015 Keiretsu Forum Mid Atlantic funding about 25 entities that presented to the forum.   Approximately 36 funding applications are submitted each month to the K4-MA DealRoom website, www.K4-DealRoom.com and vetted by industry specialists. About 10 are then vetted by members at monthly screening meetings where they participate in a highly structured presentation-and-feedback-learning session.  Three to four of the screened companies are then invited to present at subsequent monthly Forum meetings.  Entrepreneurs invited to move forward to the Forum meetings must participate in mandatory professional coaching sessions to optimize the delivery of their presentations and also agree to participate in the road show to all four cities in the region, with exposure to approximately 100 investors. Subsequently, information about their companies is posted on the organization’s online global deal room for reference by all 1500+ members. For global information visit: http://www.KeiretsuForum.com .

Vince Leusner VLeusner@KeiretsuForum.net Cell: 609-220-0988

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Nokia Corporation's Recent Management Transaction Highlights

Updated Category News Views 135

Nokia Corporation's Latest Management Transactions Nokia Corporation has recently announced significant management transactions that emphasize its ongoing operational strategies and technological innovations. Today, we dive into the details of one particular transaction involving a key manager in the company. Transaction Details This transaction notification is made under...

Continue Reading
Huawei's Innovative AI WAN Solution Revolutionizes Networking

Updated Category News Views 262

Huawei's New AI WAN Solution Unveiled At the Mobile World Congress in Barcelona, Huawei introduced the AI WAN Solution, a groundbreaking development designed to revolutionize networking. Leon Wang, the President of Huawei's Data Communication Product Line, emphasized the importance of merging AI with network infrastructures. This new solution aims to enhance IP networks...

Continue Reading
Transforming Business Dreams with Innovative Software Solutions

Updated Category News Views 114

Transforming Business Dreams with Innovative Software Solutions FM, a pioneer in custom software development augmented by AI technology, is revolutionizing how businesses approach growth and scalability. In a rapidly changing landscape, where adaptability is key, FM’s approach enables organizations to leverage generative software solutions that are more accessible than...

Continue Reading
Investment in Caesars Palace Times Square Promises Growth

Updated Category News Views 171

Community Investment and Support for Caesars Palace Times Square During a recent public hearing, community support was overwhelmingly evident for the Caesars Palace Times Square project. Local residents, small business owners, union workers, and city leaders gathered to express their enthusiasm for a project that promises to generate significant economic growth and create...

Continue Reading
Aquestive Therapeutics Reaches Milestone with FDA Notification

Updated Category News Views 114

Groundbreaking News from Aquestive Therapeutics Aquestive Therapeutics, Inc. (NASDAQ: AQST), a forward-thinking pharmaceutical company dedicated to enhancing patient care through innovative drug delivery solutions, has officially received word from the U.S. Food and Drug Administration (FDA) that no advisory committee meeting will be required for the New Drug Application...

Continue Reading